2018 to 2025 saw rise in GLP-1 receptor agonist Rx for bariatric surgery-eligible patients
Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescriptions increased from 2018 to 2025, while MBS use decreased beginning in 2023, according to a research ...
Mar 10, 2026
0
4









